{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:19:24Z","timestamp":1778901564042,"version":"3.51.4"},"reference-count":36,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T00:00:00Z","timestamp":1169683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The African Programme for Onchocerciasis Control (APOC) sponsors annual distribution of ivermectin to control onchocerciasis. Ivermectin should be taken annually by 65% of community members for a number of years to eliminate the disease as a public health problem. While many community coverage surveys have been undertaken during project monitoring, individual compliance could not be studied until several annual rounds of distribution had occurred. This paper reports on the efforts to determine whether adequate records could be found to enable a compliance study. A step\u2010down process from project to district to community level was used to identify project sites where continuous ivermectin distribution up through 2004 had occurred. The first step consisted of selecting 17 of 25 projects by APOC. The second step determined adequacy of districts where distribution had occurred on a regular annual basis. Among 121 districts 58.6% undertook distribution in all 7\u2003years. A total 852 villages were visited and community level records were found in all but three. Records showed that distribution had occurred for a minimum of five consecutive times in 429 villages, and ultimately 10 projects. While the feasibility study found an adequate number of villages to study compliance, the large number of projects, districts and villages that did not qualify for the follow\u2010on compliance study should lead National Onchocerciasis Control Programme managers to strengthen the overall coverage and consistency of their efforts.<\/jats:p>","DOI":"10.1111\/j.1365-3156.2006.01796.x","type":"journal-article","created":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T22:20:04Z","timestamp":1281565204000},"page":"260-268","source":"Crossref","is-referenced-by-count":15,"title":["Feasibility of measuring compliance to annual ivermectin treatment in the African Programme for Onchocerciasis Control"],"prefix":"10.1111","volume":"12","author":[{"given":"William R.","family":"Brieger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph C.","family":"Okeibunor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adenike O.","family":"Abiose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Ndyomugyenyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Kisoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Wanji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Elhassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uche V.","family":"Amazigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,25]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(99)00336-6"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1179\/000349802125000664"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2002.00826.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199909000-00002"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.1.78"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2004.01363.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:UROL.0000025643.80319.b3"},{"key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4269\/ajtmh.2004.70.556","article-title":"A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo state, Nigeria","volume":"70","author":"Emukah EC","year":"2004","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764170500451404"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001977"},{"key":"e_1_2_6_12_1","first-page":"290","article-title":"Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria","volume":"14","author":"Iliyasu Z","year":"2005","journal-title":"Nigerian Journal of Medicine"},{"key":"e_1_2_6_13_1","unstructured":"IPSOR Medication Compliance and Persistence Special Interest Group(2005)Standardizing definition of terms. International Society for Pharmacoeconomics and Outcomes Research.http:\/\/www.ispor.org\/sigs\/MCP_accomplishments.asp(accessed 15 March 2006)."},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2524.2002.00378.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1179\/000349802125000736"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1179\/000349804225021497"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2006.040349"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1997.d01-412.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2004.01283.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18233"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2005.01436.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.2190\/HW5T-MM3G-KE8K-61EV"},{"key":"e_1_2_6_23_1","first-page":"237","article-title":"Evaluation of community compliance with annual ivermectin treatment of onchocerciasis in Patigi, Nigeria","volume":"75","author":"Oyibo WA","year":"1998","journal-title":"East African Medical Journal"},{"key":"e_1_2_6_24_1","first-page":"237","article-title":"Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in West Africa","volume":"75","author":"Plaisier AP","year":"1997","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200303000-00006"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001859"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1258\/0956462053888826"},{"key":"e_1_2_6_28_1","first-page":"449","article-title":"Estimating medication persistency using administrative claims data","volume":"11","author":"Sikka R","year":"2005","journal-title":"The American Journal of Managed Care"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-005-0015-5"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200212153-00008"},{"key":"e_1_2_6_31_1","unstructured":"UNDP\/World Bank\/WHO.Community Directed Treatment with Ivermectin Report of a Multi\u2010Country Study.(TDR\/AFR\/RP\/96.1)UNDP\/World Bank\/WHO Special Program for research and Training in Tropical Diseases 1996 Geneva."},{"key":"e_1_2_6_32_1","volume-title":"The Involvement of Community Directed Distributors of Ivermectin in Other Health and Development Activities","author":"UNDP\/World Bank\/WHO"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E027"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ap.29.2.203"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03324587"},{"key":"e_1_2_6_36_1","first-page":"384","article-title":"Can ivermectin mass treatments eliminate onchocerciasis in Africa?","volume":"80","author":"Winnen M","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2006.00355.x"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3156.2006.01796.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3156.2006.01796.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T02:15:26Z","timestamp":1696904126000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3156.2006.01796.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,25]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1111\/j.1365-3156.2006.01796.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3156.2006.01796.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,25]]}}}